Industries > Pharma > Global Burn Care Market Report 2019-2029

Global Burn Care Market Report 2019-2029

Analysis by Product (Advanced, Biologics, Traditional), Depth (Minor, Partial-thickness, Full-thickness Burn), End-Users (Hospitals (Inpatient, Outpatient), Physician Clinics, Homecare), Company, Global Opportunity Analysis by Country and Industry Forecast

PAGES: 169
PRODUCT CODE: PHA0430

DOWNLOAD FREE SAMPLE
Clear
WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA0430 Categories: , , Tag:

Market Definition:
• Burn is an injury to skin or tissue caused due to heat, radiation, electricity, or chemicals.
• In most cases, hot liquids and fire are the common causes of burn, besides which alcoholism, smoking, and violence between people may also lead to burn injuries.
• These wounds are preventable only if few precautions are followed. While superficial burns can be managed by simple pain medications, major burns require prolonged treatment in specialized burn-care centers.

Market Overview and Trends
• Rising demand for minimally invasive procedures and treatments to improve cosmetic appeal is boosting the growth of the Burn Care Market in the upcoming years.
• Rising concern regarding aesthetic appearance among patients is a major factor attributed to the rising demand for the products available in the market are the prominent trends observed in the Burn Care Market.
• Rising demand for skin grafts is also a major growth contributor to spur the demand of Burn Care Market in the forecast year.

Market Dynamics:
Factors Influencing the Market Growth:
• Increasing incidence of burn injuries, and advancements in burn care products, are the key factors to drive the Burn Care Market.
• Increasing awareness level among people regarding the availability of various treatment options for burn care management is anticipated to boost market growth.
Factors Restraining the Market Growth:
• High cost of advanced treatments and products, lack of reimbursement, stringent regulatory requirements may hinder the growth of the market.

Market Segmentation 2019-2029:
The Burn Care Market is segmented on the by product, depth, end-user, and geography

1. Burn Care Market, By Product
a. Advanced
b. Biologics
c. Traditional

2. Burn Care Market, By Depth
a. Minor
b. Partial Thickness
c. Full Thickness

3. Burn Care Market, By End Users
a. Hospitals
b. Physician Clinics
c. Homecare

4. Burn Care Market, By Region
4.1 Introduction
4.2 North America
4.2.1 US
4.2.2 Canada
4.3 Europe
4.3.1 Germany
4.3.2 UK
4.3.3 France
4.3.4 Rest of Europe
4.4 Asia Pacific
4.4.1 Japan
4.4.2 China
4.4.3 India
4.4.4 Rest of Asia Pacific
4.5 Rest of the World (RoW)

Competitive Analysis:
• Research and development is the primary strategy adopted by the key players in the Burn Care Market.
• These companies has developed various strategies and developments such as product launch, partnerships, mergers & acquisitions, joint venture, and collaborations.

Major Market Players:
• Coloplast A/S, Smith & Nephew plc, Derma Sciences, Inc., Medtronic, Acelity L.P., 3M Company, and Mölnlycke Health Care amongst others.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Global Burn Care Market Report 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Burn Care Market Report 2019-2029


Latest Pharma news

Visiongain Publishes Mesenchymal Stem Cells Market Report 2022-2032

The mesenchymal stem cells market was valued at US$2.44 billion in 2021 and is projected to grow at a CAGR of 13.82% during the forecast period 2022-2032.

21 September 2022

READ

Visiongain Publishes Advanced Wound Care Management Market Report 2022-2032

The global advanced wound care management market is estimated to be valued at US$12,581.3 million in 2022. The market is projected to reach a market value of US$23,307.5 million by 2032 and is projected to grow at a CAGR of 6.36% during the forecast period 2022-2032.

16 September 2022

READ

Visiongain Publishes Gene Therapy R&D Market Report 2022-2032

The gene therapy R&D market was valued at US$1,653.0 million in 2021 and is projected to grow at a CAGR of 30.1% during the forecast period 2022-2032.

15 September 2022

READ

Visiongain Publishes Medical Device Contract Manufacturing Market Report 2022-2032

The medical device contract manufacturing market was valued at US$69.22 billion in 2021 and is projected to grow at a CAGR of 12.9% during the forecast period 2022-2032.

13 September 2022

READ